Evidence map›Paper›PMID 41375196›Full record

ReviewMolecules (Basel, Switzerland)2025

Blood in Capsules: Multi-Technique Forensic Investigation of Suspicious Food Supplement.

Paweł Rudnicki-Velasquez, Magdalena Popławska, Karolina Pioruńska, Marta Łaszcz, Małgorzata Milczarek, Anna Pogorzelska, Michał Karyński, Agata Błażewicz

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paweł Rudnicki-VelasquezFalsified Medicines and Medical Devices Department, National Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland.ORCID 0000-0003-0368-0112
Magdalena PopławskaFalsified Medicines and Medical Devices Department, National Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland.
Karolina PioruńskaFalsified Medicines and Medical Devices Department, National Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland.ORCID 0000-0002-4720-0494
Marta ŁaszczFalsified Medicines and Medical Devices Department, National Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland.
Małgorzata MilczarekBiomedical Research Department, National Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland.ORCID 0000-0003-1209-9477
Anna PogorzelskaBiomedical Research Department, National Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland.ORCID 0000-0002-4006-2682
Michał KaryńskiFalsified Medicines and Medical Devices Department, National Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland.
Agata BłażewiczFalsified Medicines and Medical Devices Department, National Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland.ORCID 0000-0003-2338-5153

Funding

Minister of Education Poland NdS-II/SN/0270/2023/01
6 · The paper itself

Abstract

This study presents the results of a multi-technique forensic investigation of suspicious soft capsules seized by law enforcement during a criminal case. The unlabeled samples, sold as therapeutic and "regenerative" food supplements, were examined using liquid chromatography-tandem mass spectrometry (LC-MS/MS), Fourier-transform infrared spectroscopy with attenuated total reflection (ATR-FTIR), chemiluminescence, and brightfield/confocal microscopy. These complementary analytical approaches revealed that the capsules contained biological material of unknown origin, including blood-derived compounds, lipid constituents, and cellular structures. The findings indicate biological adulteration, possibly due to deliberate falsification or severe contamination. To place these results in a broader biomedical context, a scoping review of literature on blood- and tissue-derived materials used in biomedical and nutraceutical applications was conducted. This review underscores how such products are developed, promoted, and regulated, highlighting the potential health and biosafety risks associated with unregulated biologically themed supplements. Overall, this study demonstrates a transferable analytical workflow suitable for forensic laboratories and emphasizes the need for continued regulatory vigilance to protect public health. Given the evidentiary constraints typical of forensic casework-specifically, the small amount of seized material-the workflow was optimized to maximize information yield through minimally destructive, orthogonal, non-genetic screening methods, with LC-MS/MS reserved for final molecular confirmation. DNA typing was not performed because, after confirmatory analyses, the remaining material was insufficient for reliable genotyping.

Indexed as

Dietary SupplementsCapsulesChromatography, LiquidHumansSpectroscopy, Fourier Transform InfraredTandem Mass SpectrometryCapsulesbiological adulterationforensic analysisheme detectionillicit food supplementsmulti-technique workflowscoping review

Identifiers

PMID41375196
PMCPMC12693171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.